Your browser doesn't support javascript.
loading
Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan.
Luong, Thu-Lan T; McAnulty, Michael J; Evers, David L; Reinhardt, Brian J; Weina, Peter J.
Afiliação
  • Luong TT; Walter Reed National Military Medical Center, Biomedical Laboratory, Department of Research, 8901 Rockville Pike, Bethesda, MD 20889, United States.
  • McAnulty MJ; Walter Reed National Military Medical Center, Biomedical Laboratory, Department of Research, 8901 Rockville Pike, Bethesda, MD 20889, United States.
  • Evers DL; Walter Reed National Military Medical Center, Biomedical Laboratory, Department of Research, 8901 Rockville Pike, Bethesda, MD 20889, United States.
  • Reinhardt BJ; Walter Reed National Military Medical Center, Biomedical Laboratory, Department of Research, 8901 Rockville Pike, Bethesda, MD 20889, United States.
  • Weina PJ; Walter Reed National Military Medical Center, Biomedical Laboratory, Department of Research, 8901 Rockville Pike, Bethesda, MD 20889, United States.
Curr Res Toxicol ; 2: 217-224, 2021.
Article em En | MEDLINE | ID: mdl-34345864
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article